BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hammoudeh SM, Hammoudeh AM, Bhamidimarri PM, Mahboub B, Halwani R, Hamid Q, Rahmani M, Hamoudi R. Insight into molecular mechanisms underlying hepatic dysfunction in severe COVID-19 patients using systems biology. World J Gastroenterol 2021; 27(21): 2850-2870 [PMID: 34135558 DOI: 10.3748/wjg.v27.i21.2850]
URL: https://www.wjgnet.com/1007-9327/full/v27/i21/2850.htm
Number Citing Articles
1
Mohamed A Lotfy, Ahmed A. Shama. Intensive insulin therapy improves the survival probability of non-diabetic COVID-19 patients presenting with acute hyperglycemiaEgyptian Journal of Anaesthesia 2022; 38(1): 211 doi: 10.1080/11101849.2022.2060636
2
Xiaoxi Zhang, Seungjun Ahn, Peihua Qiu, Somnath Datta. Identification of shared biological features in four different lung cell lines infected with SARS-CoV-2 virus through RNA-seq analysisFrontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1235927
3
Pratheeba Jeyananthan. Role of different types of RNA molecules in the severity prediction of SARS-CoV-2 patientsPathology - Research and Practice 2023; 242: 154311 doi: 10.1016/j.prp.2023.154311
4
O. I. Kit, E. M. Frantsiyants, D. A. Kharagezov, V. A. Bandovkina, N. D. Cheryarina, Yu. A. Pogorelova, Yu. N. Lazutin, A. G. Milakin, I. A. Leyman, O. N/ Stateshny. Indices of insulin-like growth factors family in the lung tissue of patients with non-small cell lung cancer after COVID-19 of various severitySouth Russian Journal of Cancer 2023; 4(1): 23 doi: 10.37748/2686-9039-2023-4-1-3
5
Ramesh Kumar, Vijay Kumar, Rahul Arya, Utpal Anand, Rajeev Nayan Priyadarshi. Association of COVID-19 with hepatic metabolic dysfunctionWorld Journal of Virology 2022; 11(5): 237-251 doi: 10.5501/wjv.v11.i5.237
6
Joanna K. Malinowska, Tomasz Żuradzki. Reductionist methodology and the ambiguity of the categories of race and ethnicity in biomedical research: an exploratory study of recent evidenceMedicine, Health Care and Philosophy 2023; 26(1): 55 doi: 10.1007/s11019-022-10122-y
7
SiYi TAO, Juan YUE, XianKeZi ZHONG, ShanNi LI, ZanXian XIA. Mucus hypersecretion in COVID-19 patients: signaling pathway and related targeted therapiesSCIENTIA SINICA Vitae 2023; 53(8): 1083 doi: 10.1360/SSV-2022-0251
8
Waldonio de Brito Vieira, Karen Margarete Vieira da Silva Franco, Apio Ricardo Nazareth Dias, Aline Semblano Carreira Falcão, Luiz Fábio Magno Falcão, Juarez Antonio Simões Quaresma, Rita Catarina Medeiros de Sousa. Chest Computed Tomography Is an Efficient Method for Initial Diagnosis of COVID-19: An Observational StudyFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.848656
9
Jiwei Pan, Yueying Gao, Huirui Han, Tao Pan, Jing Guo, Si Li, Juan Xu, Yongsheng Li. Multi-omics characterization of RNA binding proteins reveals disease comorbidities and potential drugs in COVID-19Computers in Biology and Medicine 2023; 155: 106651 doi: 10.1016/j.compbiomed.2023.106651
10
Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal DiseasesFrontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.753249
11
Mustafa Sertbas, Kutlu O. Ulgen. Uncovering the Effect of SARS-CoV-2 on Liver Metabolism via Genome-Scale Metabolic Modeling for Reprogramming and Therapeutic StrategiesACS Omega 2024; 9(13): 15535 doi: 10.1021/acsomega.4c00392
12
Emanuele Nicastro, Noelle H. Ebel, Mohit Kehar, Piotr Czubkowski, Vicky L. Ng, Marian G. Michaels, Steven J. Lobritto, Mercedes Martinez, Giuseppe Indolfi. The Impact of Severe Acute Respiratory Syndrome Coronavirus Type 2 on Children With Liver DiseasesJournal of Pediatric Gastroenterology and Nutrition 2022; 74(1): 159 doi: 10.1097/MPG.0000000000003339
13
Mohammad Sadiq Jeeyavudeen, Rahul Chaudhari, Joseph M Pappachan, Sherouk Fouda. Clinical implications of COVID-19 in patients with metabolic-associated fatty liver diseaseWorld Journal of Gastroenterology 2023; 29(3): 487-502 doi: 10.3748/wjg.v29.i3.487
14
Dan Li, Tao Yu, Junjie Hu, Jie Wu, Shi Feng, Qingxue Xu, Hua Zhu, Xu Zhang, Yonggang Zhang, BenHong Zhou, Lijuan Gu, Zhi Zeng, Guoku Hu. Downregulation of CYP39A1 Serves as a Novel Biomarker in Hepatocellular Carcinoma with Worse Clinical OutcomeOxidative Medicine and Cellular Longevity 2021; 2021: 1 doi: 10.1155/2021/5175581
15
Jennifer N. Kiser, Holly L. Neibergs. Identifying Loci Associated With Bovine Corona Virus Infection and Bovine Respiratory Disease in Dairy and Feedlot CattleFrontiers in Veterinary Science 2021; 8 doi: 10.3389/fvets.2021.679074